University Of Michigan Ann Arbor
Intervention significantly reduces teens’ violent behavior, anxiety, illicit substance use
A primary care intervention that consisted of one-on-one counseling and text messages significantly reduced violent behavior, anxiety and substance use among adolescents, data show.
New AAN guideline details multiple options for reducing diabetic neuropathy pain
The American Academy of Neurology has updated a guideline for treating painful diabetic neuropathy using oral and topical treatments.
Sleep problems common in children with early-life epilepsies
Parents commonly reported sleep concerns that persisted with age for children with early-life epilepsies, according to study results published in Pediatric Neurology.
Some patients may be safely discharged without opioids after cardiac surgery
For some patients who undergo cardiac surgery, discharge without an opioid prescription for pain management is feasible, researchers reported in the Annals of Thoracic Surgery.
Pathologists find evidence of usual interstitial pneumonia in people with long COVID
Usual interstitial pneumonia was a common finding in lung biopsies of people evaluated for post-COVID-19 interstitial lung disease, according to data published in EClinicalMedicine.
Physician Entrepreneurship in GI with Joe Rubinsztain, MD
In this podcast episode, Joe Rubinsztain, MD, the CEO of ChronWell, discusses his path to becoming a doctorpreneur, the creation of gMed and more.
'Just 30 days of glucocorticoid use' in RA spikes cardiovascular risk by 15% over 6 months
Among patients with rheumatoid arthritis, 30 days of glucocorticoid use in 6 months is associated with 15% increased odds of major adverse cardiac events in the next 6 months, according to data presented at ACR Convergence 2021.
Impaired vision tied to depressive symptoms in women during midlife
Vision impairment may increase risk for future depressive symptoms among women during midlife, according to study results published in Menopause: The Journal of The North American Menopause Society.
Teprotumumab effective long term, during retreatment for thyroid eye disease
Teprotumumab is effective in reducing proptosis in people with thyroid eye disease more than 2 years after treatment, and initial nonresponders to teprotumumab may benefit from a second series of infusions, according to a speaker.
Year in review: Five studies changing thyroidology practice
In an update on notable, recently conducted thyroid studies, a speaker reviewed the latest treatments and imaging modalities for children and adults that have the potential to change thyroidology practice.